Court Rulings and Travel Trends: The Impact on Abortion Pill Access

The U.S. Court of Appeals for the Fifth Circuit has ruled that the FDA must reinstate critical safeguards for chemical abortion drugs and end illegal mail-order abortions. The court found that the FDA's previous actions violated the Administrative Procedure Act and failed to consider important concerns about the safety of the drugs. Chemical abortions can cause serious health risks to women, and the court's decision reinstates necessary safeguards, including gestational limitations, office visits, adverse event reporting, and physician dispensation. This ruling holds the FDA accountable for its disregard for the law and women's health and safety.